Jefferies Group’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-11,200
Closed -$193K 2462
2018
Q3
$193K Buy
+11,200
New +$167K ﹤0.01% 2120
2018
Q1
Sell
-4,500
Closed -$52K 2589
2017
Q4
$52K Hold
4,500
﹤0.01% 2373
2017
Q3
$86K Buy
+4,500
New +$92.6K ﹤0.01% 2173
2017
Q2
Sell
-4,500
Closed -$89K 2474
2017
Q1
$89K Sell
4,500
-61,085
-93% -$1.36M ﹤0.01% 2140
2016
Q4
$1.58M Sell
65,585
-42,883
-40% -$1.19M 0.01% 1035
2016
Q3
$3.01M Buy
108,468
+88,389
+440% +$2.34M 0.02% 753
2016
Q2
$490K Hold
20,079
﹤0.01% 1460
2016
Q1
$674K Buy
+20,079
New +$632K ﹤0.01% 1307

Other funds holding PGEN

Jefferies Group's PGEN Position: Q3 2019 in Review

Jefferies Group sold out of Precigen (PGEN) in Q3 2019, closing a stake of 25,700 shares — an estimated $197K sold.

Jefferies Group first reported a position in PGEN in Q4 2014 and held it in 13 quarters. The position peaked at $2.78M in Q4 2014. 170 funds tracked by Wall St. Rank hold PGEN as of Q3 2019.

  • Jefferies Group reported no remaining Precigen position as of Q3 2019 after selling out during the quarter.
  • Jefferies Group sold 25,700 Precigen shares in Q3 2019, an estimated $197K.
  • Jefferies Group first reported a position in Precigen in Q4 2014 and held it in 13 quarters.
  • Jefferies Group's Precigen position peaked at $2.78M in Q4 2014.
  • 170 funds tracked by Wall St. Rank held Precigen as of Q3 2019.

Based on Jefferies Group's 13F filing for Q3 2019, filed 13 Nov 2019.